161 related articles for article (PubMed ID: 36741091)
1. Case report: Effectiveness of sirolimus in treating partial DiGeorge Syndrome with Autoimmune Lymphoproliferative Syndrome (ALPS)-like features.
Gu H; Mou W; Chen Z; Xie X; Yao J; Zhang R; Wu R; Gui J
Front Pediatr; 2022; 10():1014249. PubMed ID: 36741091
[TBL] [Abstract][Full Text] [Related]
2. Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial.
Bride KL; Vincent T; Smith-Whitley K; Lambert MP; Bleesing JJ; Seif AE; Manno CS; Casper J; Grupp SA; Teachey DT
Blood; 2016 Jan; 127(1):17-28. PubMed ID: 26504182
[TBL] [Abstract][Full Text] [Related]
3. Use of Sirolimus (Rapamycin) for Treatment of Cytopenias and Lymphoproliferation Linked to Autoimmune Lymphoproliferative Syndrome (ALPS). Two Case Reports.
Cayrol J; Garrido Colino C
J Pediatr Hematol Oncol; 2017 May; 39(4):e187-e190. PubMed ID: 28234735
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil and Sirolimus as second or further line treatment in children with chronic refractory Primitive or Secondary Autoimmune Cytopenias: a single centre experience.
Miano M; Scalzone M; Perri K; Palmisani E; Caviglia I; Micalizzi C; Svahn J; Calvillo M; Banov L; Terranova P; Lanza T; Dufour C; Fioredda F
Br J Haematol; 2015 Oct; 171(2):247-253. PubMed ID: 26058843
[TBL] [Abstract][Full Text] [Related]
5. Approaches to Managing Autoimmune Cytopenias in Novel Immunological Disorders with Genetic Underpinnings Like Autoimmune Lymphoproliferative Syndrome.
Rao VK
Front Pediatr; 2015; 3():65. PubMed ID: 26258116
[TBL] [Abstract][Full Text] [Related]
6. Sirolimus is effective in autoimmune lymphoproliferative syndrome-type III: A pedigree case report with homozygous variation PRKCD.
Gu H; Chen Z; Ma J; Wang J; Zhang R; Wu R; Wang T
Int J Immunopathol Pharmacol; 2021; 35():20587384211025934. PubMed ID: 34187243
[TBL] [Abstract][Full Text] [Related]
7. [Autoimmune disorder secondary to DiGeorge syndrome: a long-term follow-up case report and literature review].
Xie Y; Guo JQ; Hua Y; Zhao WH; Sun Q; Lu XT
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 48(6):1086-1089. PubMed ID: 27987519
[TBL] [Abstract][Full Text] [Related]
8. Case report: Neonatal autoimmune lymphoproliferative syndrome with a novel pathogenic homozygous
Elgharbawy FM; Karim MY; Soliman DS; Hassan AS; Sudarsanan A; Gad A
Front Pediatr; 2023; 11():1150179. PubMed ID: 37152306
[TBL] [Abstract][Full Text] [Related]
9. Case report: Effectiveness of sirolimus in a
Gu H; Chen Z; Ma J; Ma J; Fu L; Zhang R; Wang T; Wu R
Front Pediatr; 2022; 10():868193. PubMed ID: 35967554
[TBL] [Abstract][Full Text] [Related]
10. Immune cytopenias as a continuum in inborn errors of immunity: An in-depth clinical and immunological exploration.
Zama D; Conti F; Moratti M; Cantarini ME; Facchini E; Rivalta B; Rondelli R; Prete A; Ferrari S; Seri M; Pession A
Immun Inflamm Dis; 2021 Jun; 9(2):583-594. PubMed ID: 33838017
[TBL] [Abstract][Full Text] [Related]
11. Opinion paper: effectiveness of sirolimus in treating partial Di George syndrome with autoimmune lymphoproliferative syndrome-like features.
van der Werff Ten Bosch J
Front Pediatr; 2023; 11():1242652. PubMed ID: 38078335
[TBL] [Abstract][Full Text] [Related]
12. Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).
Li P; Huang P; Yang Y; Hao M; Peng H; Li F
Clin Rev Allergy Immunol; 2016 Feb; 50(1):55-63. PubMed ID: 25663566
[TBL] [Abstract][Full Text] [Related]
13. [A case of autoimmune lymphoproliferactive syndrome and literature review].
Liu L; Hu J; Ma J; Li X; Li F; Li C
Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):923-6. PubMed ID: 25619350
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS).
Teachey DT; Obzut DA; Axsom K; Choi JK; Goldsmith KC; Hall J; Hulitt J; Manno CS; Maris JM; Rhodin N; Sullivan KE; Brown VI; Grupp SA
Blood; 2006 Sep; 108(6):1965-71. PubMed ID: 16757690
[TBL] [Abstract][Full Text] [Related]
15. An autoimmune lymphoproliferative syndrome initially diagnosed as Evans syndrome.
Uysal Z; Ertem M; Talia İleri D; Doğu F; Azık FM; İkincioğulları A; Gözdaşoğlu S
Turk J Haematol; 2007 Jun; 24(2):80-4. PubMed ID: 27263622
[TBL] [Abstract][Full Text] [Related]
16. 22q11.2 distal deletion: a recurrent genomic disorder distinct from DiGeorge syndrome and velocardiofacial syndrome.
Ben-Shachar S; Ou Z; Shaw CA; Belmont JW; Patel MS; Hummel M; Amato S; Tartaglia N; Berg J; Sutton VR; Lalani SR; Chinault AC; Cheung SW; Lupski JR; Patel A
Am J Hum Genet; 2008 Jan; 82(1):214-21. PubMed ID: 18179902
[TBL] [Abstract][Full Text] [Related]
17. [Primary immunodeficiencies presenting with autoimmune cytopenias in adults].
Sève P; Broussolle C; Pavic M
Rev Med Interne; 2013 Mar; 34(3):148-53. PubMed ID: 22703729
[TBL] [Abstract][Full Text] [Related]
18. Optimal Management of Autoimmune Lymphoproliferative Syndrome in Children.
George LA; Teachey DT
Paediatr Drugs; 2016 Aug; 18(4):261-72. PubMed ID: 27139496
[TBL] [Abstract][Full Text] [Related]
19. A case report of T-box 1 mutation causing phenotypic features of chromosome 22q11.2 deletion syndrome.
Haddad RA; Clines GA; Wyckoff JA
Clin Diabetes Endocrinol; 2019; 5():13. PubMed ID: 31428446
[TBL] [Abstract][Full Text] [Related]
20. DiGeorge syndrome with microdeletion of chromosome 22q11.2: report of one case.
Wang JL; Chen SJ; Chung MY; Niu DM; Lin CY; Hwang BT; Lu JH
Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1997; 38(5):385-9. PubMed ID: 9401184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
